ミズーリ州における喘息の臨床試験
ミズーリ州内の拠点で、喘息に関する11件の研究が参加者を募集しています。
ミズーリ州内の都市
公式研究テキスト（英語）
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07645248ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, St Louis
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/24更新 · NCT07301255A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Washington University School of Medicine, St Louis
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/09/22更新 · NCT06977581Resources and Education for Addressing Chronic Health (REACH)
- WashU School of Medicine, St Louis
被験者募集中
3歳〜18歳 · 全性別 · 2026/09/21更新 · NCT07819747CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
- Affinia healthcare, 2220 Lemp Ave, St Louis
- Affinia healthcare, 1717 Biddle Street, St Louis
- Affinia healthcare, 4414 North Florissant Avenue, St Louis
- 他4件
被験者募集中第4相
12歳以上 · 全性別 · 2026/09/10更新 · NCT07241117A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12149, Columbia
- Teva Investigational Site 12108, St Louis
- Teva Investigational Site 12089, St Louis
被験者募集中第3相
12歳以上 · 全性別 · 2026/08/31更新 · NCT06664619A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Columbia
被験者募集中第2相
4歳〜11歳 · 全性別 · 2026/08/27更新 · NCT07525375Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Kansas City
- Research Site, St Louis
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/08/13更新 · NCT06307665A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Kansas City
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07532265Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
- GSK Investigational Site, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/02更新 · NCT06979323Individualizing Treatment for Asthma in Primary Care (Full Study)
- University of Missouri, Columbia
被験者募集中第4相
13歳〜75歳 · 全性別 · 2025/10/29更新 · NCT07052942ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。